Zydus

The WHO emergency-use licence puts the ball back in the court of Bharat Biotech. (File)The World Health Organization’s (WHO) emergency-use licence to Bharat Biotech’s Covaxin recently ended…

Bharat Biotech is evaluating immunogenicity, reactogenicity and safety of Covaxin on healthy volunteers belonging above the age of 2 years at six places. (Representative Image_Covid-19…

New Delhi, October 3 With talks underway between the central government and Zydus Cadila over the pricing of the Covid-19 vaccine ZyCov-D,…

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D,…

New Delhi, October 3 With talks underway between the central government and Zydus Cadila over the pricing of the Covid-19 vaccine ZyCov-D,…

According to Patel, Zydus Cadila had invested Rs 500 crore in developing the vaccine and in the manufacturing capacity with further investments expected as manufacturing capacity was being…

Drug firm Zydus Cadila on Saturday said it is looking to supply its COVID-19 vaccine ZyCoV-D by the middle to end of September, adding the pricing of the dose will be announced in the next…

The Science and Technology Ministry statement said: "Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D…

CDSCO on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use authorisation in adults and children aged 12 years and aboveIndia’s drug regulator, Central Drugs…

A day after emergency use approval was granted to the Zydus Cadila Covid-19 vaccine, the pharma major has said that the price of the vaccine will be decided by next week. Managing Director…